6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors
The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives (Formula (I)) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ("mGluR2"). The invention is also directed to pharmaceutical compositions comprising such c...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Trabanco-Suárez, Andrés Delgado-González, Óscar Van Gool, Michiel Andrés-Gil, José Alonso-De Diego, Sergio-Alvar |
| description | The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives (Formula (I)) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ("mGluR2"). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_NZ728122A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>NZ728122A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_NZ728122A3</originalsourceid><addsrcrecordid>eNqFijsLwjAURrs4iPoX5I4KzdBorauI4uTkpEgJyW0bSHNDHkL99T5wd_rOOXzjbNjkFVO6G5QnN3jxJEO3Ii-ZuH9VW7ZelN2SkUWQ1DtKVgUQVkHsUHtIAUEEsNiKqB9vNoZCRK8l9KSSEZF8AGqgb03yHDxKdJ82zUaNMAFnv51k8-Phsj8xdFRjcEKixVifrxXfFpzvVn8PL6zRRKw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors</title><source>esp@cenet</source><creator>Trabanco-Suárez, Andrés ; Delgado-González, Óscar ; Van Gool, Michiel ; Andrés-Gil, José ; Alonso-De Diego, Sergio-Alvar</creator><creatorcontrib>Trabanco-Suárez, Andrés ; Delgado-González, Óscar ; Van Gool, Michiel ; Andrés-Gil, José ; Alonso-De Diego, Sergio-Alvar</creatorcontrib><description>The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives (Formula (I)) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ("mGluR2"). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220729&DB=EPODOC&CC=NZ&NR=728122A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220729&DB=EPODOC&CC=NZ&NR=728122A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Trabanco-Suárez, Andrés</creatorcontrib><creatorcontrib>Delgado-González, Óscar</creatorcontrib><creatorcontrib>Van Gool, Michiel</creatorcontrib><creatorcontrib>Andrés-Gil, José</creatorcontrib><creatorcontrib>Alonso-De Diego, Sergio-Alvar</creatorcontrib><title>6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors</title><description>The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives (Formula (I)) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ("mGluR2"). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFijsLwjAURrs4iPoX5I4KzdBorauI4uTkpEgJyW0bSHNDHkL99T5wd_rOOXzjbNjkFVO6G5QnN3jxJEO3Ii-ZuH9VW7ZelN2SkUWQ1DtKVgUQVkHsUHtIAUEEsNiKqB9vNoZCRK8l9KSSEZF8AGqgb03yHDxKdJ82zUaNMAFnv51k8-Phsj8xdFRjcEKixVifrxXfFpzvVn8PL6zRRKw</recordid><startdate>20220729</startdate><enddate>20220729</enddate><creator>Trabanco-Suárez, Andrés</creator><creator>Delgado-González, Óscar</creator><creator>Van Gool, Michiel</creator><creator>Andrés-Gil, José</creator><creator>Alonso-De Diego, Sergio-Alvar</creator><scope>EVB</scope></search><sort><creationdate>20220729</creationdate><title>6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors</title><author>Trabanco-Suárez, Andrés ; Delgado-González, Óscar ; Van Gool, Michiel ; Andrés-Gil, José ; Alonso-De Diego, Sergio-Alvar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_NZ728122A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Trabanco-Suárez, Andrés</creatorcontrib><creatorcontrib>Delgado-González, Óscar</creatorcontrib><creatorcontrib>Van Gool, Michiel</creatorcontrib><creatorcontrib>Andrés-Gil, José</creatorcontrib><creatorcontrib>Alonso-De Diego, Sergio-Alvar</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Trabanco-Suárez, Andrés</au><au>Delgado-González, Óscar</au><au>Van Gool, Michiel</au><au>Andrés-Gil, José</au><au>Alonso-De Diego, Sergio-Alvar</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors</title><date>2022-07-29</date><risdate>2022</risdate><abstract>The present invention relates to novel 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5H)-one derivatives (Formula (I)) as negative allosteric modulators (NAMs) of the metabotropic glutamate receptor subtype 2 ("mGluR2"). The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds and compositions for the prevention or treatment of disorders in which the mGluR2 subtype of metabotropic receptors is involved.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_NZ728122A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 6,7-dihydropyrazolo[1,5-a]pyrazin-4(5h)-one compounds and their use as negative allosteric modulators of mglur2 receptors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A13%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Trabanco-Su%C3%A1rez,%20Andr%C3%A9s&rft.date=2022-07-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ENZ728122A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |